分类: health

  • Health Authorities call for preparedness despite forecasts of a below-normal 2026 Atlantic hurricane season

    Health Authorities call for preparedness despite forecasts of a below-normal 2026 Atlantic hurricane season

    As the 2026 Atlantic hurricane season gets underway, the Pan American Health Organization (PAHO) has issued an urgent call to governments across the Americas to revisit their disaster contingency frameworks and ramp up readiness measures. The goal is to shield regional health systems from cascading harms triggered by hurricanes, flash floods, landslides and other extreme weather events that routinely hit the hemisphere.

    Current long-range forecasts suggest the 2026 storm season will be less active than the unusually intense periods recorded in recent years, but PAHO has stressed that this milder projection does not eliminate risk. Even one single powerful hurricane, the organization notes, can upend routine health care delivery and create severe, widespread threats to public health that outlast the storm itself.

    “Extreme hydrometeorological events remain a constant threat across the Americas,” stated Leonardo Hernández, director of PAHO’s Emergency Operations Unit. “Preparing health systems before an emergency strikes is non-negotiable if we want to save lives, keep critical care accessible to all those who need it, and cut down on the disproportionate harm these events inflict on the most vulnerable populations.”

    Beyond the immediate destruction of critical health infrastructure and the interruption of essential services like vaccinations and chronic disease management, hurricanes and subsequent flooding create a cascade of secondary public health risks. These include elevated rates of waterborne illnesses such as cholera and typhoid, increased transmission of vector-borne diseases spread by mosquitoes, higher rates of respiratory infections from damp, crowded post-storm living conditions, a surge in storm-related injuries, and long-term negative mental health outcomes for affected communities. The public health emergencies sparked by extreme weather also add unplanned, overwhelming strain to health systems that are already operating at or beyond capacity in many parts of the region.

    To address these risks, PAHO is urging all at-risk countries to verify that every level of their health system has up-to-date contingency plans, fully trained emergency response personnel, and clear cross-agency coordination mechanisms in place. These systems are critical to ensuring essential health services can continue operating during a storm and recover quickly in its aftermath. The organization also recommends expanding disease surveillance infrastructure and community-based monitoring networks, which enable early detection and rapid response to the unique public health risks that follow extreme weather events.

    According to forecast data from the U.S. National Oceanic and Atmospheric Administration (NOAA), the 2026 Atlantic hurricane season is projected to see below-normal activity, largely driven by the formation of El Niño conditions in the Pacific. El Niño, defined by above-average sea surface temperatures across the central and eastern Pacific, typically creates wind patterns that suppress the formation of tropical cyclones in the Atlantic basin. However, PAHO points out that El Niño also reshapes rainfall and temperature trends across the Americas, increasing the chance of extreme events including droughts, intense downpours, flooding and landslides across different subregions of the hemisphere, even when hurricane activity is low.

    Preparedness takes on added urgency in 2026 due to the region’s ongoing epidemiological context, PAHO says. Countries across the Americas are already responding to ongoing outbreaks of measles and yellow fever, and must maintain readiness for other emerging and re-emerging public health threats. When a climate emergency overlaps with existing infectious disease outbreaks, health systems are quickly stretched beyond their breaking point, crippling their ability to meet the sudden surge in demand for care during and after an extreme weather event.

    To support national governments in their preparedness work, PAHO will host a virtual regional readiness meeting on June 11, bringing together representatives from health ministries and national disaster risk management agencies from every country in the Americas. The gathering will focus on updating and strengthening protocols for health service management, epidemiological surveillance, and emergency operations, while integrating key lessons identified during previous extreme weather and public health events.

    The meeting will also advance the implementation of the World Health Organization’s 2025 National Health Emergency Preparedness, Alert and Response Framework. This global framework promotes a multi-hazard approach to emergency readiness built around five core functional systems: collaborative cross-agency surveillance, community-centered protection, safe and scalable acute care, equitable access to medical countermeasures, and integrated emergency coordination.

    Looking beyond the June meeting, PAHO says it will continue its long-term work with member states to strengthen national emergency preparedness plans and intersectoral coordination mechanisms at both the national and local levels. This ongoing support is designed to ensure that countries can launch timely, effective responses when extreme weather events or other public health emergencies strike, ultimately saving lives and reducing harm to vulnerable communities.

  • Minister of Health Tours Key Healthcare Infrastructure Projects

    Minister of Health Tours Key Healthcare Infrastructure Projects

    In a proactive push to evaluate the resilience and future readiness of Antigua and Barbuda’s national healthcare network, Honorable Michael Joseph – the country’s Minister of Health, Wellness, Environment and Civil Service Affairs – launched a full-day tour of key medical facilities and ongoing infrastructure projects on Wednesday.

    Accompanying Minister Joseph on the inspection tour were senior government stakeholders, including Permanent Secretary Stacey Gregg-Paige, Head of Infrastructure Gary Thomas, and Telly Cornelius, a designated representative from the Ministry of Works. The interagency delegation kicked off their itinerary at the Grays Farm Dental Clinic, where Dr. Derek Marshall, head of the national Dental Unit, greeted the team and led a detailed walkthrough of the clinic’s existing operational spaces.

    During talks held after the tour, participants centered their conversation on two core priorities: examining the potential for expanding the clinic’s physical footprint, and evaluating whether adding new specialized oral health services would be practical and sustainable for the facility. The on-site visit allowed officials to gather first-hand data on the clinic’s current service capacity, laying the groundwork for targeted upgrades that align with both the public’s immediate oral health needs and the ministry’s long-term strategic development goals.

    Following the stop at the dental clinic, the delegation moved to inspect the government’s new morgue facility, where they received up-to-date briefings on the pace of ongoing construction works. The team closely reviewed the infrastructure’s progress, as the facility is purpose-built to bolster national pathology services and support related medical testing operations.

    The tour’s next stop was the new renal care facility currently under development. Once construction wraps up and the facility opens to patients, it is projected to dramatically transform renal care delivery across the country, creating more comfortable treatment environments and expanding access to life-sustaining dialysis services for patients in need.

    Officials also received progress updates on the construction of the new CARE Project facility, a flagship government initiative focused on expanding care and support services for children living with special needs.

    Speaking after the conclusion of the tour, Minister Joseph emphasized that these on-site inspections are not isolated events, but rather part of a cross-sector nationwide program of engagement and evaluation across Antigua and Barbuda’s health sector. He underlined that the government’s top priority is ensuring all public healthcare facilities are properly resourced with cutting-edge equipment, developed in line with long-term strategic planning, and fully equipped to meet both the current and future healthcare demands of the population.

    To date, the Ministry of Health, Wellness, Environment and Civil Service Affairs has reaffirmed its unwavering commitment to expanding and modernizing the country’s healthcare infrastructure, with the end goal of improving equitable access to high-quality medical services for every resident of Antigua and Barbuda.

  • Scientist warns of possible climate link to hantavirus outbreaks

    Scientist warns of possible climate link to hantavirus outbreaks

    As a growing body of scientific research investigates whether shifting climate patterns are accelerating the geographic spread of hantavirus – a life-threatening pathogen transmitted primarily through rodents – a leading Caribbean-based biosecurity expert is urging regional communities to boost surveillance, preparedness, and diagnostic capacity to mitigate emerging risks.

    Dr. Kirk Douglas, director of the Centre for Biosecurity Studies at The University of the West Indies’ Cave Hill campus in Barbados, says that while the approaching El Niño event, a climate pattern linked to elevated global temperatures, does not guarantee an imminent hantavirus outbreak in the region, it serves as a critical early warning signal. This signal, he argues, should prompt governments and public health authorities to roll out proactive measures including expanded rodent population monitoring and functional early warning systems where resources allow.

    Global public health data already reflects worrying shifts in hantavirus transmission. Globally, the virus has caused three confirmed fatalities among 13 documented cases to date, and in Argentina – where a high-profile outbreak linked to the MV Hondius cruise ship drew international attention in recent weeks – annual confirmed cases have more than doubled over the last 12 months. Scientists are currently working to unpack the specific climate and ecological drivers that are allowing the pathogen to take hold in regions where it was previously rare or undetected.

    Douglas emphasized that the spread of hantavirus and other emerging pathogens into new geographic ranges is not an act of nature, but a consequence of unregulated human activity that disrupts natural ecosystems. “Outbreaks like this remind us that human health is not separate from ecological or environmental health,” he explained. When humans clear forests for resource extraction, reduce biodiversity by oversimplifying natural ecosystems, mismanage solid waste, expand urban development into untouched animal habitats, intensify agricultural production without proper environmental safeguards, and ignore clear climate warning signs, they create far more opportunities for dangerous pathogens to jump across species barriers to humans, he argued.

    Crucially, Douglas stressed that this does not mean nature itself is the enemy. “The problem is unmanaged contact, ecological disruption, and weak preparedness, which all boils down to human behaviour. We need a more respectful, intelligent relationship with the natural world, one that recognises public health, climate resilience, biodiversity, agriculture, tourism, waste management and urban planning, as all part of the same interconnected system.”

    Hantavirus itself is an ancient pathogen, Douglas noted, but the risk it poses to communities today is a distinctly modern challenge tied to human disruption of natural systems. “The health of people, animals and ecosystems…we can no longer govern them separately,” he said. “We have to have transdisciplinary approaches to the way we tackle diseases; and I believe that human behaviour is by far the most critical factor that we need to target.”

    Beyond ecosystem disruption and climate-driven spread, Douglas also warned that widespread misdiagnosis poses a major underaddressed risk to Barbados and the broader Caribbean. Many common regional viral diseases present nearly identical early symptoms: hantavirus, dengue, Zika, chikungunya, and Oropouche virus all cause acute febrile illness that can be hard to distinguish without targeted testing. In many cases, he explained, clinicians default to a diagnosis of dengue – the most common of these pathogens – without conducting confirmatory laboratory testing, simply because it is faster and more convenient. This practice not only hides the true scope of circulating pathogens in the region, but can also delay life-saving treatment for less common diseases like hantavirus.

    To address this gap, Douglas called on clinicians to systematically ask patients about potential exposure risks, including recent travel, contact with rodent populations, activities like cleaning enclosed rarely used spaces, farming, or camping that can increase the chance of encountering the virus. For clinical laboratories, he recommended updating testing protocols to account for exposure history, geographic location, seasonal patterns, and clinical severity, rather than automatically testing only for the most common endemic disease. Drawing on his own doctoral research, which documented cases of co-infection between dengue and hantavirus, Douglas noted that the landscape of circulating pathogens in the Caribbean is shifting rapidly. New pathogens are emerging or being detected every few years, he explained, and many of these may have been present in the region for decades without detection due to lack of targeted testing.

    “Having multiple diagnostics and referral pathways will be very, very important” to address the changing threat landscape, Douglas concluded.

  • UWI researcher contributes to major Lancet series highlighting global kidney disease crisis

    UWI researcher contributes to major Lancet series highlighting global kidney disease crisis

    A leading researcher from The University of the West Indies (The UWI) has contributed her regional expertise to a groundbreaking new series published in *The Lancet*, which sounds the alarm on the rapidly escalating global public health crisis posed by chronic kidney disease (CKD), an underdiagnosed condition that impacts hundreds of millions of people across the world.

    Dr. Lori-Ann Fisher, a consultant nephrologist, intensivist and lecturer based at the Epidemiology Research Unit of The UWI’s Caribbean Institute for Health Research (CAIHR), was invited to join a team of top international specialists assembled to produce the landmark series. The project is led by Dr. Jennifer Lees of the University of Glasgow, and its core conclusion classifies CKD as one of the fastest-growing major threats to global public health, while issuing a urgent call for increased global investment in prevention, early identification, and accessible treatment.

    “Chronic kidney disease remains one of the most concerning conditions currently impacting global health,” Dr. Lees emphasized in the series’ lead commentary. “The overriding message from our series of research papers is that there remains a pressing need for attention and resources to be focused on this condition.”

    Current global data puts CKD as the ninth leading cause of death worldwide, with an estimated 844 million people living with the condition today. If unaddressed, the series warns that current prevalence and mortality trends will push CKD to become the fifth leading cause of global death by 2040. One of the biggest barriers to tackling CKD, researchers note, is its silent progression: the disease often develops with no obvious warning signs through its early and intermediate stages, meaning most cases are only diagnosed once it reaches an advanced stage, when patients already require life-sustaining interventions like dialysis or organ transplantation.

    While the CKD burden is rising globally, low- and middle-income regions with limited public health infrastructure face disproportionate challenges. The Caribbean is no exception: data from the Jamaica Health and Lifestyle Survey shows that roughly 15 percent of Jamaicans live with CKD, and a large share of those cases are already advanced or at high risk of rapid progression when detected.

    For Dr. Fisher, who has spent her career researching CKD epidemiology, sickle cell-related kidney disease, lupus nephritis, and CKD prevalence across the Caribbean, the key to improving regional outcomes lies in expanding early detection. “We now have accessible medications that treat kidney disease and reduce progression to kidney failure,” she explained. “In the Caribbean, where access to transplant and dialysis is limited, detecting kidney disease early is crucial to improve outcomes. Investment in strengthening healthcare systems to detect and treat kidney disease is paramount for the health of our nations.”

    The *Lancet* series confirms this approach, noting that simple, low-cost blood and urine tests can effectively identify CKD in early stages, dramatically improving patient prognoses. Despite this proven tool, routine CKD screening is not integrated into standard care across most global healthcare systems, particularly in low-resource regions.

    Dr. Fisher’s participation in the series underscores The UWI’s longstanding commitment to addressing pressing regional and global health challenges through rigorous, context-aware research and evidence-based policy advocacy. Beyond her academic and clinical work at The UWI, Fisher currently serves as Chair of the North America and Caribbean Regional Board of the International Society of Nephrology, where she works to amplify Caribbean voice and priorities in global kidney health initiatives.

  • Public Health reports 10 new cases of dengue in the last week

    Public Health reports 10 new cases of dengue in the last week

    Public health officials in the Dominican Republic have released their latest epidemiological update for the 20th surveillance week of the year, outlining new case counts across a range of endemic and infectious diseases, as well as ongoing circulation patterns for common respiratory pathogens. The update, published by the nation’s Ministry of Public Health from the capital Santo Domingo, paints a mixed picture of disease transmission across the country, with most metrics tracking near or below recent seasonal averages.

    On dengue, one of the Caribbean region’s most persistent vector-borne endemic diseases, the ministry confirmed 10 new diagnoses across the country over the seven-day reporting period. This brings the cumulative total of confirmed dengue cases recorded since the start of the year to 111. Geographically, the bulk of cases have been concentrated in just a handful of provinces: La Altagracia leads all regions with 29 total confirmed cases, followed by Valverde with 8. Single additional cumulative cases have been recorded in San Cristóbal, La Vega, and Puerto Plata to date. When compared to the same reporting week in 2025, when 11 new dengue cases were logged, officials noted a small but measurable slight reduction in new infections.

    Turning to another endemic vector-borne illness, malaria, the update recorded four new confirmed cases over the past week. All of the new malaria diagnoses were in male patients, and all were detected in the southwestern province of San Juan. For the full year to date, the cumulative national count of confirmed malaria cases stands at 83. As with dengue, cases are heavily geographically concentrated: Azua province accounts for more than 62 percent of all national cases at 52, while San Juan follows with 20 confirmed cases.

    Leptospirosis, a bacterial infection spread through contact with water contaminated by animal urine, has also been tracked by officials. The ministry’s update puts the cumulative national case count at 149 confirmed infections so far this year, with two new cases added to the tally in the capital province of Santo Domingo during the 20th epidemiological week.

    Beyond infectious disease case counts, the report also included the latest data on maternal and infant mortality. Over the past week, three new maternal deaths and 27 new infant deaths were recorded across the country. Since the start of 2026, the cumulative total of maternal deaths reported nationwide stands at 46.

    On the respiratory virus front, public health authorities confirmed that multiple common pathogens remain in active circulation across the Dominican Republic. These include human metapneumovirus, parainfluenza, adenovirus, and influenza A subtype H3N2. In a key development, officials noted that SARS-CoV-2, the virus that causes COVID-19, has seen a steady increase in case counts over recent weeks and is now the most prevalent circulating respiratory virus in the country. The 20th week update recorded two new confirmed SARS-CoV-2 cases, alongside one new case of human metapneumovirus.

    The ministry added that it continues to maintain active surveillance for severe acute respiratory infections (SARI), which are currently circulating alongside less severe influenza-like illness (ILI). As of the latest update, the overall situation for influenza-like illness “remains within expected parameters,” with no unexpected surges or new concerning variants reported.

    As a reminder for the general public, the Ministry of Public Health reissued basic background information on COVID-19: the disease can cause a wide spectrum of severity, ranging from mild cold-like symptoms to life-threatening complications including pneumonia and severe acute respiratory syndrome. Common symptomatic presentations include a dry cough, sore throat, persistent fatigue, loss of smell or taste, shortness of breath, and nasal congestion. The virus spreads primarily through close contact with infected individuals, or via contact with contaminated surfaces and objects.

  • Infectious disease specialist warns of the risk of Ebola to the country

    Infectious disease specialist warns of the risk of Ebola to the country

    SANTO DOMINGO, DOMINICAN REPUBLIC — An Ebola outbreak spreading rapidly in the northwest of the Democratic Republic of the Congo demands global vigilance, including targeted preparedness measures from Dominican public health authorities, a leading local infectious disease specialist has warned. Dr. Hector Balcácer stressed that even geographically distant disease outbreaks carry modern spillover risks in an interconnected world, where a person can travel to nearly any corner of the globe in just 36 hours. The DRC has already implemented movement restrictions and quarantine measures to curb transmission, but Balcácer noted the nation shares open borders with nine neighboring countries, and cross-border population movement remains highly fluid in the region.

    In an interview with journalists Ramón García and Tomás Aquino Méndez on the Ahora TV Channel 3 current affairs program *Al punto vespertino*, Balcácer outlined the uniquely dangerous nature of the current outbreak. Unlike previous Ebola events, the virus is spreading at an accelerated pace, and no approved curative treatment or preventative vaccine is currently available. With a mortality rate between 40% and 60% — meaning four to six out of every 10 confirmed infections result in death — the virus poses a severe public health threat wherever it gains a foothold. “The most worrying thing about all of this is that this disease has no treatment, no vaccine, no cure,” Balcácer stated. “Where it arrives, it can cause high mortality. It is a disease that cannot be stopped with existing medical tools.”

    Balcácer commended the ongoing public warnings issued by local and global health authorities, noting that coordinated vigilance remains the most effective defense against cross-border spread. Contrary to widespread public anxiety, however, the specialist clarified that the outbreak is not currently projected to develop into a full global pandemic. The swift implementation of quarantine and movement restrictions by the DRC government has already slowed potential spread, reducing the immediate global risk.

    Even so, Balcácer insisted that Dominican authorities must adopt extreme precautionary measures to block the virus from entering the country, given its lethal characteristics and lack of targeted treatment. Alongside his warning about Ebola, the specialist also addressed the ongoing circulation of more common seasonal viruses within the Dominican Republic, a situation the country’s Ministry of Health has already publicly reported. Currently circulating pathogens include seasonal influenza, adenovirus, respiratory syncytial virus (RSV), and SARS-CoV-2, the virus that causes COVID-19 — though Balcácer noted current COVID-19 variants are far less lethal than earlier strains.

    To prevent severe complications from these common viruses, Balcácer urged Dominican residents to seek prompt medical care as soon as symptoms develop, a step that significantly reduces the risk of severe illness. He added that patients over 70 years old require particularly rapid and rigorous care to avoid life-threatening complications. For those with access to testing resources, Balcácer recommended taking a COVID-19 test when experiencing viral symptoms to rule out infection and enable appropriate care.

  • Eastern Caribbean labs link up for faster outbreak response

    Eastern Caribbean labs link up for faster outbreak response

    A regional initiative to boost infectious disease monitoring, early outbreak detection and rapid public health response across the Eastern Caribbean is now underway, after the Pan American Health Organization (PAHO) concluded a targeted stakeholder consultation focused on building tier-based compliant laboratory networks. The multi-day gathering, hosted at Saint Lucia’s Harbour Club Hotel, brought together a diverse cohort of laboratory specialists, public health practitioners, sub-regional reference laboratory leaders and global health partner representatives from across the island bloc.

    The core goal of the consultation was to align regional stakeholders on the infrastructure, policy and operational requirements for building a tier-based laboratory network that meets the binding standards of the International Health Regulations (IHR) and aligns with global universal health coverage (UHC) goals. Unlike a centralized model, a tier-based system connects diagnostic facilities across multiple levels of care: from community-based testing sites at local polyclinics, to national reference laboratories, up to specialized regional reference centers. This interconnected structure is designed to cut wait times for diagnostic results, expand equitable access to testing, and deliver more consistent, reliable data to trigger faster outbreak responses.

    Vishwanath Partapsingh, PAHO’s advisor for health systems and services, outlined the dual core objectives of the regional consultation in opening remarks. “First, we wanted to open a collaborative dialogue with member states to build shared understanding of the core principles of tier-based laboratory networks, outline the tangible benefits these systems deliver, map existing national laboratory capacity across the region, and outline actionable next steps for each country to advance their own systems,” Partapsingh explained. “Second, we aimed to assess current progress countries have already made toward aligning their laboratory infrastructure with IHR requirements, and create space for cross-national experience sharing. Countries across the Eastern Caribbean are at different stages of developing these networks, so there is tremendous value in allowing nations to learn from one another’s successes and challenges.”

    For host nation Saint Lucia, the timing of the consultation proved particularly opportune, according to Dr. Glensford Joseph, the country’s Medical Officer of Health. Joseph noted that the gathering created a critical space for collaboration with other member states of the Organization of Eastern Caribbean States (OECS) to strengthen regional and national laboratory services collectively.

    “This consultation gives us a unique opportunity to conduct a full review of our current national laboratory framework, identify unaddressed gaps and challenges, and lay the groundwork to build a far more robust diagnostic system that serves communities across every level of care,” Joseph said. “Right now, we are preparing to expand routine laboratory services out to the community level, particularly in our island’s polyclinics, so this guidance could not have come at a better time as we shift to a tier-based approach.”

    Joseph added that Saint Lucia’s Ministry of Health prioritizes this regional collaboration because it helps national policymakers refine existing frameworks and actionable roadmaps to strengthen laboratory systems, work that directly advances both UHC goals and national outbreak preparedness efforts.

    “A strong, tiered laboratory network enables the decentralization of diagnostic services, meaning community members can access the testing they need close to home, which is a critical pillar of rolling out our national universal health coverage package,” Joseph emphasized. “Beyond improving access to routine care, strengthening this network is also central to boosting our national disease surveillance capacity. Laboratory diagnosis is the foundation of confirming outbreak-causing pathogens, enabling faster clinical management for patients and allowing public health teams to bring outbreaks under control far more quickly.”

    Looking ahead, PAHO expects that the outcomes of this consultation will drive measurable progress in rolling out tier-based laboratory systems across multiple Eastern Caribbean nations, including Saint Lucia, Grenada, and St. Vincent and the Grenadines, ultimately improving health outcomes and security for communities across the sub-region.

  • Cuba resumes production of cytostatic drugs

    Cuba resumes production of cytostatic drugs

    Against a backdrop of crippling economic constraints and a steadily tightening U.S. economic, commercial, and financial blockade, Cuba has marked a major milestone in protecting public health: the full restart of production at the AICA Laboratories cytostatic drug facility, following a targeted expansion investment designed to boost domestic output of critical cancer treatments.

    The reopening event, held on June 5, 2026, brought together senior leaders from Cuba’s biopharmaceutical sector and public health system, including BioCubaFarma president Mayda Mauri Pérez, who hosted Minister of Public Health José Angel Portal Miranda during an official tour of the upgraded facility. The visit underscored the close cross-sector collaboration between the national biopharmaceutical industry, the Ministry of Public Health (Minsap), and the Cuban government – a partnership that officials say was instrumental to completing the expansion and restart despite the country’s ongoing external pressures.

    Per an official update shared to BioCubaFarma’s Facebook page, the production restart is being carried out as a gradual, carefully monitored process. Each stage of manufacturing will be brought online incrementally, a deliberate approach chosen to guarantee consistent technological stability and adherence to Cuba’s strict quality standards for pharmaceutical products.

    Following the expansion, the upgraded plant is now positioned to supply 16 different cytostatic (cancer-fighting) medications to Cuba’s National Program for the Care of Cancer Patients. Production scheduling has been structured to prioritize the drugs classified as most clinically critical, aligned with needs assessments coordinated directly with Minsap.

    Speaking during the reopening ceremony, Portal Miranda emphasized that even amid widespread economic limitations, the facility’s return to operation represents a critical step forward in securing consistent access to life-saving cancer treatments for the Cuban people. Mayda Mauri Pérez echoed this sentiment, noting that the intersectoral alliance between the biopharmaceutical and public health sectors has emerged as an essential bulwark protecting drug access for Cubans, even as the U.S. blockade has intensified in recent years.

    The event also included participation from practicing Cuban oncologists, who held working discussions with facility leadership to align production priorities with real-time clinical needs on the ground. This direct input ensures that output from the plant will directly address the most pressing care demands facing patients across the country.

    Far from being an isolated infrastructure milestone, the restart of the AICA Laboratories plant stands as a clear illustration of the coordinated mission that unites Cuba’s biotechnology sector and public health system: to guarantee access to essential medications for all citizens, regardless of external pressures. For a country grappling with externally induced supply shortages, every treatment produced at this expanded facility represents more than just medicine – it is a testament to Cuban public health sovereignty, a source of hope for thousands of patients and families, and a reaffirmation of the state’s longstanding commitment to the universal right to health.

  • UWI Researcher Among Experts in Landmark Global Study on Chronic Kidney Disease

    UWI Researcher Among Experts in Landmark Global Study on Chronic Kidney Disease

    Chronic kidney disease (CKD) has quietly emerged as one of the fastest-growing public health threats across the globe, and a new landmark research series published in *The Lancet* is sounding the alarm over the need for urgent, coordinated action. Among the leading international experts contributing to this pivotal work is Dr. Lori-Ann Fisher, a consultant nephrologist, intensivist and lecturer based at the Epidemiology Research Unit of the Caribbean Institute for Health Research (CAIHR) at The University of the West Indies (The UWI).

    Led by Dr. Jennifer Lees of the University of Glasgow, the multi-paper series frames CKD as a rapidly escalating global health crisis, and calls for sweeping improvements in three core areas: early diagnosis, preventive care, and accessible treatment. In her commentary on the research, Lees emphasized that CKD remains one of the most underaddressed, high-impact conditions affecting global populations today. “The overriding message from our series of research papers is that there remains a pressing need for attention and resources to be focused on this condition,” Lees noted.

    Current global health data underscores the scale of the problem: CKD is already the ninth leading cause of death worldwide, affecting an estimated 844 million people across all income regions. Projections from the study indicate that without targeted intervention, CKD will climb to become the fifth leading cause of global death by 2040. What makes this burden even more striking is the widespread gap in diagnosis: even as cases rise, CKD remains vastly underdetected, a gap that is particularly acute in low- and middle-income regions such as the Caribbean, where public awareness and routine screening infrastructure remain limited.

    For the Caribbean, the CKD burden carries uniquely severe consequences. Data from the Jamaica Health and Lifestyle Survey shows that roughly 15% of Jamaicans are currently living with CKD, and a large share of those patients are already diagnosed at advanced or high-risk stages of the disease. For Fisher, who has spent years researching CKD epidemiology across the region, the path to better outcomes hinges entirely on earlier detection. In the Caribbean, access to life-saving interventions like kidney transplants and long-term dialysis is severely limited, making early intervention far more critical than in better-resourced regions. “We now have accessible medications that treat kidney disease and reduce progression to kidney failure,” Fisher explained. “In the Caribbean, where access to transplant and dialysis is limited, detecting kidney disease early is crucial to improve outcomes. Investment in strengthening healthcare systems to detect and treat kidney disease is paramount for the health of our nations.”

    One of the core barriers to early detection that the study highlights is CKD’s asymptomatic progression. In early and moderate stages, most patients experience no obvious symptoms, leading to delayed testing and treatment that often only begins once the disease has reached its most severe stages, when organ replacement therapy is already the only viable option. The research confirms that simple, low-cost urine and blood tests can effectively diagnose CKD in its early stages, but routine implementation of these screenings remains inconsistent across most national healthcare systems.

    Fisher’s participation in this landmark global publication is far from an isolated contribution; it reflects The UWI’s decades-long commitment to addressing pressing regional and global health challenges through rigorous research and evidence-based policy advocacy. As a specialist with deep expertise in CKD epidemiology, sickle cell nephropathy, and lupus nephritis in the Caribbean context, Fisher has built a career advancing understanding of CKD prevalence and associated risk factors across Jamaica and the wider Caribbean. She currently also serves as Chair of the International Society of Nephrology (ISN) North America and Caribbean Regional Board, working to amplify the region’s voice in global kidney health priority-setting.

    Now in its 76th year of operation, The UWI has grown from its 1948 founding as a small London-affiliated university college in Jamaica with just 33 medical students into a world-class, globally recognized institution serving nearly 50,000 students across five physical campuses and a global online network. Today, the university’s campuses include Mona in Jamaica, St. Augustine in Trinidad and Tobago, Cave Hill in Barbados, Five Islands in Antigua and Barbuda, and its fully online Global Campus, with additional research and academic partnerships with leading institutions across North America, Latin America, Asia, Africa, and Europe.

    Offering more than 1,000 certificate, diploma, undergraduate and postgraduate degree programs across fields ranging from creative arts and engineering to law, medical sciences, and social policy, The UWI stands as the Caribbean’s leading academic institution, home to the region’s largest concentration of research expertise focused on solving the most critical challenges facing Caribbean and global communities. Since 2018, The UWI has held a consistent place in *Times Higher Education* (THE) annual global university rankings, and it remains the only English-speaking Caribbean institution to be featured across four of THE’s most prestigious ranking categories: the World University Rankings, which evaluate more than 2,000 leading research-focused universities globally; the Golden Age University Rankings for institutions founded between 50 and 80 years ago; the Latin America and Caribbean Rankings; and the Impact Rankings, which assess universities based on their contributions to the United Nations’ Sustainable Development Goals (SDGs). This global recognition has also supported the launch of the university’s International School for Development Justice (ISDJ), a global online graduate business school focused on training the next generation of leaders to advance equitable sustainable development. As an SDG-engaged university consistently ranked among the world’s top institutions for impact, The UWI continues to center pressing public health challenges like CKD at the core of its research mission.

  • Spanish Town Hospital urology unit marks five years with 1,500 surgeries completed

    Spanish Town Hospital urology unit marks five years with 1,500 surgeries completed

    KINGSTON, Jamaica — Five years after launching, the specialized urology department at Jamaica’s public Spanish Town Hospital has emerged as a critical regional care hub, closing in on a major professional milestone: nearly 1,500 completed surgical procedures for patients across St Catherine and adjacent parishes. What began as a small targeted service has rapidly expanded access to life-saving urological treatment that once required long, costly travel for local residents.

    First established on May 3, 2021, the unit has not only delivered surgical care but also treated thousands of patients through outpatient services, earning its place as one of the nation’s top public-sector urology centers, per an official statement released Friday by the hospital.

    Dr. Elon Thompson, consultant urologist and founding head of the service, emphasized that the five-year achievement is the product of collective effort across the entire facility’s healthcare team. “This milestone belongs to an entire team of committed healthcare professionals who have worked tirelessly to improve access to specialised urological care for the people of St Catherine and beyond,” Thompson noted in the official release.

    Over its five years of operation, the unit has notched a series of progressive clinical firsts that demonstrate its growing technical capacity. In January 2022, the team completed the hospital’s first ever radical cystectomy — a complex, high-stakes procedure that removes cancerous bladder tissue to treat urological cancer. Just 20 months later, in September 2023, the hospital performed its first laparoscopic nephrectomy, pushing the unit’s ability to offer minimally invasive surgical options that reduce patient risk and recovery time.

    The department has also prioritized addressing one of the most common urological cancers in the region: it has carried out more than 150 prostate cancer-focused procedures to date, including curative radical prostatectomies that eliminate early-stage cancer from patients.

    Most recently, in July 2025, the unit upgraded its technical capabilities with the acquisition of a new surgical laser system. The equipment enables minimally invasive kidney stone procedures, expanding the range of treatments available to local patients while cutting recovery periods and boosting overall surgical success rates.

    For residents of St Catherine and surrounding communities, the growth of the on-site urology service has eliminated a major barrier to care. Prior to the department’s launch, local patients often had to travel long distances to larger urban centers to access even basic specialized urological treatment, a burden that added cost, stress, and delay to care. The service has now drastically reduced that need, bringing high-quality specialty care closer to home.

    Looking forward, the urology team has laid out clear goals for continued growth: expanding access to additional advanced urological procedures, creating more hands-on training opportunities for emerging healthcare professionals in the field, and steadily improving patient outcomes across the entire region.

    “While we are proud of what has been accomplished, our work is far from complete. We remain committed to building on these achievements and ensuring that the people we serve continue to have access to high-quality, modern urological care close to home,” Thompson said.